These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 20660728)
1. Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma. Ma T; Jham BC; Hu J; Friedman ER; Basile JR; Molinolo A; Sodhi A; Montaner S Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14363-8. PubMed ID: 20660728 [TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-like 4: a novel molecular hallmark in oral Kaposi's sarcoma. Hu J; Jham BC; Ma T; Friedman ER; Ferreira L; Wright JM; Accurso B; Allen CM; Basile JR; Montaner S Oral Oncol; 2011 May; 47(5):371-5. PubMed ID: 21421336 [TBL] [Abstract][Full Text] [Related]
3. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma. Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770 [TBL] [Abstract][Full Text] [Related]
4. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis? Sodhi A; Montaner S; Gutkind JS FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988 [TBL] [Abstract][Full Text] [Related]
5. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma. Jham BC; Ma T; Hu J; Chaisuparat R; Friedman ER; Pandolfi PP; Schneider A; Sodhi A; Montaner S PLoS One; 2011 Apr; 6(4):e19103. PubMed ID: 21559457 [TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Vart RJ; Nikitenko LL; Lagos D; Trotter MW; Cannon M; Bourboulia D; Gratrix F; Takeuchi Y; Boshoff C Cancer Res; 2007 May; 67(9):4042-51. PubMed ID: 17483315 [TBL] [Abstract][Full Text] [Related]
7. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524 [TBL] [Abstract][Full Text] [Related]
8. The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia. Montaner S; Sodhi A; Servitja JM; Ramsdell AK; Barac A; Sawai ET; Gutkind JS Blood; 2004 Nov; 104(9):2903-11. PubMed ID: 15231571 [TBL] [Abstract][Full Text] [Related]
9. The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. Jensen KK; Manfra DJ; Grisotto MG; Martin AP; Vassileva G; Kelley K; Schwartz TW; Lira SA J Immunol; 2005 Mar; 174(6):3686-94. PubMed ID: 15749907 [TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma virally encoded, G-protein-coupled receptor: a paradigm for paracrine transformation. Martin D; Gutkind JS Methods Enzymol; 2009; 460():125-50. PubMed ID: 19446723 [TBL] [Abstract][Full Text] [Related]
11. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Sodhi A; Chaisuparat R; Hu J; Ramsdell AK; Manning BD; Sausville EA; Sawai ET; Molinolo A; Gutkind JS; Montaner S Cancer Cell; 2006 Aug; 10(2):133-43. PubMed ID: 16904612 [TBL] [Abstract][Full Text] [Related]
13. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma. Medina MV; D Agostino A; Ma Q; Eroles P; Cavallin L; Chiozzini C; Sapochnik D; Cymeryng C; Hyjek E; Cesarman E; Naipauer J; Mesri EA; Coso OA PLoS Pathog; 2020 Oct; 16(10):e1009006. PubMed ID: 33057440 [TBL] [Abstract][Full Text] [Related]
14. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene. Jham BC; Montaner S J Cell Biochem; 2010 May; 110(1):1-9. PubMed ID: 20213674 [TBL] [Abstract][Full Text] [Related]
15. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene. Martin D; Nguyen Q; Molinolo A; Gutkind JS Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663 [TBL] [Abstract][Full Text] [Related]
16. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048 [TBL] [Abstract][Full Text] [Related]
18. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229 [TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Bais C; Van Geelen A; Eroles P; Mutlu A; Chiozzini C; Dias S; Silverstein RL; Rafii S; Mesri EA Cancer Cell; 2003 Feb; 3(2):131-43. PubMed ID: 12620408 [TBL] [Abstract][Full Text] [Related]
20. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. Cannon M; Philpott NJ; Cesarman E J Virol; 2003 Jan; 77(1):57-67. PubMed ID: 12477810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]